BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 7828438)

  • 1. The in vivo roles of müllerian-inhibiting substance.
    Behringer RR
    Curr Top Dev Biol; 1994; 29():171-87. PubMed ID: 7828438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The müllerian inhibitor and mammalian sexual development.
    Behringer RR
    Philos Trans R Soc Lond B Biol Sci; 1995 Nov; 350(1333):285-8; discussion 289. PubMed ID: 8570693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal sexual development in transgenic mice chronically expressing müllerian inhibiting substance.
    Behringer RR; Cate RL; Froelick GJ; Palmiter RD; Brinster RL
    Nature; 1990 May; 345(6271):167-70. PubMed ID: 2336108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Müllerian inhibiting substance signaling uses a bone morphogenetic protein (BMP)-like pathway mediated by ALK2 and induces SMAD6 expression.
    Clarke TR; Hoshiya Y; Yi SE; Liu X; Lyons KM; Donahoe PK
    Mol Endocrinol; 2001 Jun; 15(6):946-59. PubMed ID: 11376113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Müllerian-inhibiting substance function during mammalian sexual development.
    Behringer RR; Finegold MJ; Cate RL
    Cell; 1994 Nov; 79(3):415-25. PubMed ID: 7954809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic studies of MIS signalling in sexual development.
    Jamin SP; Arango NA; Mishina Y; Behringer RR
    Novartis Found Symp; 2002; 244():157-64; discussion 164-8, 203-6, 253-7. PubMed ID: 11990789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The marsupial male: a role model for sexual development.
    Renfree MB; Harry JL; Shaw G
    Philos Trans R Soc Lond B Biol Sci; 1995 Nov; 350(1333):243-51. PubMed ID: 8570688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic studies of the AMH/MIS signaling pathway for Müllerian duct regression.
    Jamin SP; Arango NA; Mishina Y; Hanks MC; Behringer RR
    Mol Cell Endocrinol; 2003 Dec; 211(1-2):15-9. PubMed ID: 14656471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Müllerian inhibiting substance is present in embryonic testes of dogs with persistent müllerian duct syndrome.
    Meyers-Wallen VN; Lee MM; Manganaro TF; Kuroda T; Maclaughlin D; Donahoe PK
    Biol Reprod; 1993 Jun; 48(6):1410-8. PubMed ID: 8318594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Müllerian inhibiting substance: an instructive developmental hormone with diagnostic and possible therapeutic applications.
    Teixeira J; Maheswaran S; Donahoe PK
    Endocr Rev; 2001 Oct; 22(5):657-74. PubMed ID: 11588147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear receptor steroidogenic factor 1 regulates the müllerian inhibiting substance gene: a link to the sex determination cascade.
    Shen WH; Moore CC; Ikeda Y; Parker KL; Ingraham HA
    Cell; 1994 Jun; 77(5):651-61. PubMed ID: 8205615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New insights into mullerian inhibiting substance and its mechanism of action.
    Lane AH; Donahoe PK
    J Endocrinol; 1998 Jul; 158(1):1-6. PubMed ID: 9713320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Müllerian inhibiting substance in reproduction and cancer.
    Donahoe PK
    Mol Reprod Dev; 1992 Jun; 32(2):168-72. PubMed ID: 1637555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Snaring the genes that divide the sexes for mammals.
    Marx J
    Science; 1995 Sep; 269(5232):1824-5. PubMed ID: 7569916
    [No Abstract]   [Full Text] [Related]  

  • 15. Involvement of a matrix metalloproteinase in MIS-induced cell death during urogenital development.
    Roberts LM; Visser JA; Ingraham HA
    Development; 2002 Mar; 129(6):1487-96. PubMed ID: 11880357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mullerian inhibiting substance: an update.
    MacLaughlin DT; Donahoe PK
    Adv Exp Med Biol; 2002; 511():25-38; discussion 38-40. PubMed ID: 12575754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The nuclear receptor SF-1 mediates sexually dimorphic expression of Mullerian Inhibiting Substance, in vivo.
    Giuili G; Shen WH; Ingraham HA
    Development; 1997 May; 124(9):1799-807. PubMed ID: 9165127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The serine/threonine transmembrane receptor ALK2 mediates Müllerian inhibiting substance signaling.
    Visser JA; Olaso R; Verhoef-Post M; Kramer P; Themmen AP; Ingraham HA
    Mol Endocrinol; 2001 Jun; 15(6):936-45. PubMed ID: 11376112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mullerian inhibiting substance: a fetal hormone with surgical implications.
    Hutson JM; Donahoe PK; Budzik GP
    Aust N Z J Surg; 1985 Dec; 55(6):599-605. PubMed ID: 2870703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Welcome to the family: the anti-müllerian hormone receptor.
    Grootegoed JA; Baarends WM; Themmen AP
    Mol Cell Endocrinol; 1994 Apr; 100(1-2):29-34. PubMed ID: 8056154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.